Laboratorios Del Dr. Esteve S.a.

Susana Yenes Minguez

Antoni Torrens Jover

Alberto Dordal Zueras

Luz Romero Alonso

Helmut Heinrich Buschmann

Monica Garcia Lopez

Antonio Torrens Jover

Mónica Garcia Lopez

Jose Mas Prio

Helmut Henrich Buschmann

The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

[object Object]

The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

5-HT7 receptor antagonists

The present invention relates to indoline-substituted pyrazoline compounds of formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals. 

Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments

The present invention relates to Cycloalkane-substituted substituted pyrazoline compounds of formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals. 

Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments

The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Growing community of inventors

Barcelona, Spain

Susana Yenes Minguez